Modulation of Rhamm (CD168) for selective adipose tissue development
Patent
·
OSTI ID:1130537
Herein is described the methods and compositions for modulation of Rhamm, also known as CD 186, and its effects on wound repair, muscle differentiation, bone density and adipogeneisis through its ability to regulate mesenchymal stem cell differentiation. Compositions and methods are provided for blocking Rhamm function for selectively increasing subcutaneous, but not, visceral fat. Compositions and methods for modulating Rhamm in wound repair are also described.
- Research Organization:
- LBNL (Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States))
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC02-05CH11231
- Assignee:
- The Regents of the University of California (Oakland, CA)
- Patent Number(s):
- 8,715,653
- Application Number:
- 12/515,405
- OSTI ID:
- 1130537
- Country of Publication:
- United States
- Language:
- English
Similar Records
Uncovering the dual role of RHAMM as an HA receptor and a regulator of CD44 expression in RHAMM-expressing mesenchymal progenitor cells
Site-specific differences of insulin action in adipose tissue derived from normal prepubertal children
Translin modulates mesenchymal cell proliferation and differentiation in mice
Journal Article
·
Wed Oct 14 20:00:00 EDT 2015
· Frontiers in Cell and Developmental Biology
·
OSTI ID:1629220
Site-specific differences of insulin action in adipose tissue derived from normal prepubertal children
Journal Article
·
Mon Aug 15 00:00:00 EDT 2005
· Experimental Cell Research
·
OSTI ID:20717647
Translin modulates mesenchymal cell proliferation and differentiation in mice
Journal Article
·
Sat Sep 15 00:00:00 EDT 2018
· Biochemical and Biophysical Research Communications
·
OSTI ID:23103538